Communicating genetics research results to families: problems arising when the patient participant is deceased. od Ormondroyd, E, Moynihan, C, Ardern-Jones, A, Eeles, R, Foster, C, Davolls, S, Watson, M

Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives. od Ormondroyd, E, Moynihan, C, Watson, M, Foster, C, Davolls, S, Ardern-Jones, A, Eeles, R

Identification of new genetic risk factors for prostate cancer. od Guy, M, Kote-Jarai, Z, Giles, G, Al Olama, A, Jugurnauth, S, Mulholland, S, Leongamornlert, D, Edwards, S, Morrison, J, Field, H, Southey, M, Severi, G, Donovan, J, Hamdy, F, Dearnaley, D, Muir, K, Smith, C, Bagnato, M, Ardern-Jones, A, Hall, A, O'Brien, LT, Gehr-Swain, B, Wilkinson, R, Cox, A, Lewis, S

Multiple newly identified loci associated with prostate cancer susceptibility. od Eeles, R, Kote-Jarai, Z, Giles, G, Olama, A, Guy, M, Jugurnauth, S, Mulholland, S, Leongamornlert, D, Edwards, S, Morrison, J, Field, H, Southey, M, Severi, G, Donovan, J, Hamdy, F, Dearnaley, D, Muir, K, Smith, C, Bagnato, M, Ardern-Jones, A, Hall, A, O'Brien, LT, Gehr-Swain, B, Wilkinson, R, Cox, A

Multiple loci on 8q24 associated with prostate cancer susceptibility. od Al Olama, A, Kote-Jarai, Z, Giles, G, Guy, M, Morrison, J, Severi, G, Leongamornlert, D, Tymrakiewicz, M, Jhavar, S, Saunders, E, Hopper, J, Southey, M, Muir, K, English, DR, Dearnaley, D, Ardern-Jones, A, Hall, A, O'Brien, LT, Wilkinson, R, Sawyer, E, Lophatananon, A, Horwich, A, Huddart, R, Khoo, V, Parker, C

Multiple loci with different cancer specificities within the 8q24 gene desert. od Ghoussaini, M, Song, H, Koessler, T, Al Olama, A, Kote-Jarai, Z, Driver, K, Pooley, K, Ramus, S, Kjaer, S, Hogdall, E, DiCioccio, R, Whittemore, A, Gayther, SA, Giles, G, Guy, M, Edwards, S, Morrison, J, Donovan, J, Hamdy, F, Dearnaley, D, Ardern-Jones, A, Hall, A, O'Brien, LT, Gehr-Swain, B, Wilkinson, R

Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers od Page, EC, Bancroft, EK, Brook, MN, Assel, M, Battat, M, Thomas, S, Taylor, N, Chamberlain, A, Pope, J, Raghallaigh, HN, Evans, DG, Rothwell, J, Mahle, L, Grindedal, EMM, James, P, Mascarenhas, L, McKinley, J, Side, L, Thomas, T, Van Asperen, C, Vasen, H, Kiemeney, LA, Ringelberg, J, Jensen, TD, Osther, PJS, Helfand, BT, Genova, E, Oldenburg, RA, Cybulski, C, Wokolorczyk, D, Ong, K-R, Huber, C, Lam, J, Taylor, L, Salinas, M, Feliubadaló, L, Oosterwijk, JC, Van Zelst-Stams, W, Cook, J, Rosario, DJ, Domchek, S, Powers, J, Buys, S, O'Toole, K, Ausems, MGEM, Schmutzler, RK, Rhiem, K, Izatt, L, Tripathi, V, Teixeira, MR, Cardoso, M, Foulkes, WD, Aprikian, A, Van Randeraad, H, Davidson, R, Longmuir, M, Ruijs, MWG, Van Den Enden, ATJM, Adank, M, Williams, R, Andrews, L, Murphy, DG, Halliday, D, Walker, L, Liljegren, A, Carlsson, S, Azzabi, A, Jobson, I, Morton, C, Shackleton, K, Snape, K, Hanson, H, Harris, M, Tischkowitz, M, Taylor, A, Kirk, J, Susman, R, Chen-Shtoyerman, R, Spigelman, A, Pachter, N, Ahmed, M, Cajal, T, Zgajnar, J, Brewer, C, Gadea, N, Brady, AF, Van Os, T, Gallagher, D, Johannsson, O, Donaldson, A, Barwell, J, Nicolai, N, Friedman, E, Obeid, E, Greenhalgh, L, Murthy, V, Copakova, L, Saya, S, McGrath, J, Cooke, P, Rønlund, K, Richardson, K, Henderson, A, Teo, SH, Arun, B, Kast, K, Dias, A, Aaronson, NK, Ardern-Jones, A, Bangma, CH, Castro, E, Dearnaley, D, Eccles, DM, Tricker, K, Eyfjord, J, Falconer, A, Foster, C, Gronberg, H, Hamdy, FC, Stefansdottir, V, Khoo, V, Lindeman, GJ, Lubinski, J, Axcrona, K, Mikropoulos, C, Mitra, A, Moynihan, C, Rennert, G, Suri, M, Wilson, P, Dudderidge, T, Impact Study Collaborators, Offman, J, Kote-Jarai, Z, Vickers, A, Lilja, H, Eeles, RA